Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease-Reference-Cited by-同舟云学术

Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease

Published:2024-02-27 Issue:4 Volume:102 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Adesuyan Matthew¹^ORCID,Jani Yogini H.¹,Alsugeir Dana¹,Howard Robert¹,Ju Chengsheng¹^ORCID,Wei Li¹,Brauer Ruth¹

Affiliation:

1. From the Research Department of Practice and Policy (M.A., Y.H.J., D.A., C.J., L.W., R.B.), UCL School of Pharmacy; Centre for Medicines Optimisation Research and Education (M.A., Y.H.J.), University College London Hospitals NHS Foundation Trust, United Kingdom; Pharmacy Practice Department (D.A.), College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia; and Division of Psychiatry (R.H.), University College London, United Kingdom.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000209131

Reference42 articles.

1. Projections of care for older people with dementia in England: 2015 to 2040

2. Owen-Williams R. Leading Causes of Death, UK: 2001 to 2018. Office for National Statistics; 2020. Accessed February 3, 2023. ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/articles/leadingcausesofdeathuk/2001to2018.

3. The estimation of the global prevalence of dementia from 1990‐2019 and forecasted prevalence through 2050: An analysis for the Global Burden of Disease (GBD) study 2019

4. US Food & Drug Administration. FDA grants accelerated approval for Alzheimer's drug: Aducanumab [online]. Accessed March 8 2023. fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-drug.

5. US Food & Drug Administration. FDA grants accelerated approval for Alzheimer's drug: Lecanemab [online]. Accessed March 8 2023. fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach;Biomedicines;2024-08-19

2. Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies;Journal of Alzheimer's Disease;2024-08-13

3. Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis;Neurological Sciences;2024-05-25

4. Association between prescription drugs and all-cause mortality risk in the UK population;2024-03-10

5. Repurposing Erectile Dysfunction Medication for Alzheimer Disease Prevention;Neurology;2024-02-27